Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept

Area of Science:

• Psychiatry
• Neurology
• Clinical Psychology

Background:

• Bipolar disorder (BD) encompasses distinct subtypes, primarily Bipolar I (BD-1) and Bipolar II (BD-2).
• Understanding the phenotypic differences between BD-1 and BD-2 is crucial for accurate diagnosis and effective treatment strategies.

Purpose of the Study:

• To conduct a comparative analysis of the descriptive, psychopathological, and treatment characteristics differentiating Bipolar I (BD-1) and Bipolar II (BD-2) disorder patients.
• To elucidate the distinct clinical profiles of BD-1 versus BD-2 to inform diagnostic criteria and therapeutic approaches.

Main Methods:

• A cohort of 1377 adult patients diagnosed with bipolar disorder was evaluated.
• Data collection included descriptive, psychopathological, and treatment variables.
• Statistical analyses employed bivariate methods and logistic multivariable modeling to compare BD-1 and BD-2 groups.

Main Results:

• Bipolar II disorder patients exhibited more familial affective disorder, later onset, higher education, and better socioeconomic status compared to BD-1.
• BD-2 was associated with more general medical diagnoses, less substance abuse, longer depressive episodes, higher depression and anxiety ratings, and a depression-predominant course.
• BD-2 patients showed distinct symptom profiles on the HDRS21, with increased depression, guilt, suicidality, and anxiety, and less psychomotor retardation or paranoia; treatment often involved antidepressants and benzodiazepines, with less use of lithium or antipsychotics.

Conclusions:

• Bipolar II disorder is characterized by more prolonged depressive episodes, with some hypomanic and mixed features, but lacks the manic or psychotic episodes typical of BD-1.
• Despite higher socioeconomic and functional status, individuals with BD-2 experience significant long-term morbidity and carry a considerable risk of suicidal behavior.
• The findings support the classification of BD-1 and BD-2 as distinct syndromes, highlighting that BD-2 is not necessarily less severe than BD-1 due to its unique clinical presentation and associated risks.